$2.36
5.42% yesterday
Nasdaq, Nov 15, 10:08 pm CET
ISIN
US7743741024
Symbol
RMTI

Rockwell Medical, Inc. Target price 2024 - Analyst rating & recommendation

Rockwell Medical, Inc. Classifications & Recommendation:

Buy
100%

Rockwell Medical, Inc. Price Target

Target Price $6.67
Price $2.36
Potential
Number of Estimates 3
3 Analysts have issued a price target Rockwell Medical, Inc. 2025 . The average Rockwell Medical, Inc. target price is $6.67. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 3 analysts: 3 Analysts recommend Rockwell Medical, Inc. to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Rockwell Medical, Inc. stock has an average upside potential 2025 of . Most analysts recommend the Rockwell Medical, Inc. stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 83.61 100.11
14.83% 19.73%
EBITDA Margin -6.26% 4.98%
67.90% 179.61%
Net Margin -13.92% -0.32%
83.41% 97.70%

3 Analysts have issued a sales forecast Rockwell Medical, Inc. 2024 . The average Rockwell Medical, Inc. sales estimate is

$100m
Unlock
. This is
1.20% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$102m 2.63%
Unlock
, the lowest is
$98.8m 0.12%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $83.6m 14.83%
2024
$100m 19.73%
Unlock
2025
$83.7m 16.42%
Unlock
2026
$76.8m 8.17%
Unlock
2027
$69.4m 9.67%
Unlock
2028
$74.9m 7.93%
Unlock

2 Analysts have issued an Rockwell Medical, Inc. EBITDA forecast 2024. The average Rockwell Medical, Inc. EBITDA estimate is

$5.0m
Unlock
. This is
79.86% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$5.5m 97.26%
Unlock
, the lowest is
$4.5m 62.45%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-5.2m 63.14%
2024
$5.0m 195.26%
Unlock
2025
$764k 84.67%
Unlock
2026
$141k 81.53%
Unlock
2027
$-700k 596.45%
Unlock
2028
$2.4m 442.86%
Unlock

EBITDA Margin

2023 -6.26% 67.90%
2024
4.98% 179.61%
Unlock
2025
0.91% 81.73%
Unlock
2026
0.18% 80.22%
Unlock
2027
-1.01% 661.11%
Unlock
2028
3.20% 416.83%
Unlock

3 Rockwell Medical, Inc. Analysts have issued a net profit forecast 2024. The average Rockwell Medical, Inc. net profit estimate is

$-320k
Unlock
. This is
83.50% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$650k 133.52%
Unlock
, the lowest is
$-970k 49.98%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-11.6m 80.95%
2024
$-320k 97.25%
Unlock
2025
$-1.8m 471.88%
Unlock
2026
$-2.3m 23.50%
Unlock
2027
$-970k 57.08%
Unlock
2028
$1.9m 300.00%
Unlock

Net Margin

2023 -13.92% 83.41%
2024
-0.32% 97.70%
Unlock
2025
-2.19% 584.38%
Unlock
2026
-2.94% 34.25%
Unlock
2027
-1.40% 52.38%
Unlock
2028
2.59% 285.00%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -0.36 -0.01
80.95% 97.22%
P/E negative
EV/Sales 0.72

3 Analysts have issued a Rockwell Medical, Inc. forecast for earnings per share. The average Rockwell Medical, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-0.01
Unlock
. This is
83.33% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$0.02 133.33%
Unlock
, the lowest is
$-0.03 50.00%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-0.36 80.95%
2024
$-0.01 97.22%
Unlock
2025
$-0.06 500.00%
Unlock
2026
$-0.07 16.67%
Unlock
2027
$-0.03 57.14%
Unlock
2028
$0.06 300.00%
Unlock

P/E ratio

Current -40.05 1,807.14%
2024
-235.50 488.01%
Unlock
2025
-41.56 82.35%
Unlock
2026
-33.64 19.06%
Unlock
2027
-78.50 133.35%
Unlock
2028
39.25 150.00%
Unlock

Based on analysts' sales estimates for 2024, the Rockwell Medical, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.73 2.82%
2024
0.72 1.45%
Unlock
2025
0.86 19.66%
Unlock
2026
0.94 8.90%
Unlock
2027
1.04 10.71%
Unlock
2028
0.96 7.35%
Unlock

P/S ratio

Current 0.77 11.18%
2024
0.76 1.18%
Unlock
2025
0.91 19.65%
Unlock
2026
0.99 8.89%
Unlock
2027
1.10 10.71%
Unlock
2028
1.02 7.34%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today